GAITHERSBURG, Md.--(BUSINESS WIRE)--Smithers Avanza announced that Dr. Michael Dorato has been appointed as Executive Vice President, Smithers Avanza Development Services, effective April 7, 2014. Dorato will report to Smithers Group President and CEO, Michael Hochschwender.
As the leader of the Development Services group at the Smithers Avanza facility in Gaithersburg, Maryland, Dorato has responsibility for the business, operations, scientific services, and quality teams. Dorato has nearly 35 years of experience in the pharmaceutical and CRO industries, and holds a Ph.D. and M.S. in Pharmacology from St. John's University.
Prior to joining Smithers, he served as Vice President and CSO of Global Discovery Services at Covance and Executive Director of Toxicology at Eli Lilly and Company. In these positions, Dorato directed teams in safety and efficacy lead optimization, investigative and regulatory toxicology, discovery and late phase pathology, animal welfare, molecular and anatomical imaging, in vivo pharmacology, veterinary medicine and model development.
"With his background and expertise in leading toxicology and pharmacology business units, it is clear that Dr. Dorato understands the technical and operational aspects of running a toxicology facility. I am confident that our clients will benefit from his scientific knowledge and that his business leadership experience will lead to growth and new opportunities to service our market," said Hochschwender, President and CEO of The Smithers Group.
Smithers Avanza is a contract research organization known for superior quality, on-time delivery, flexibility, and responsiveness. For more information about Smithers Avanza's development and pharmaceutical solutions, visit www.smithersavanza.com.
About Smithers Avanza
Smithers Avanza is a contract research organization known for superior quality, on-time delivery, flexibility, and responsiveness. Our laboratories support the pharmaceutical and chemical industries. At our GLP, cGMP, and AAALAC accredited facilities, our Development Services group offers general toxicology, safety pharmacology, vaccine safety testing, DART, and experimental medicine/efficacy models. Our Pharmaceutical Services offerings include PK/TK, biomarker assays, immunogenicity, clinical chemistry, and bioassays.
Contacts
Smithers Avanza
Hope Aubin, + 1 508-295-2550